H

Healius Ltd
ASX:HLS

Watchlist Manager
Healius Ltd
ASX:HLS
Watchlist
Price: 1.35 AUD 2.66% Market Closed
Market Cap: 980.3m AUD
Have any thoughts about
Healius Ltd?
Write Note

Healius Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Healius Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
H
Healius Ltd
ASX:HLS
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Healthia Ltd
ASX:HLA
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sonic Healthcare Ltd
ASX:SHL
Effect of Foreign Exchange Rates
-AU$11.5m
CAGR 3-Years
29%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Integral Diagnostics Ltd
ASX:IDX
Effect of Foreign Exchange Rates
-AU$219k
CAGR 3-Years
36%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Capitol Health Ltd
ASX:CAJ
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Australian Clinical Labs Ltd
ASX:ACL
Effect of Foreign Exchange Rates
-AU$25k
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Healius Ltd
Glance View

Market Cap
980.2m AUD
Industry
Health Care

Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.

HLS Intrinsic Value
3.18 AUD
Undervaluation 58%
Intrinsic Value
Price
H

See Also

Back to Top